AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metzer GV 1mg/500mg/0.3mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Tanzer Lifecare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Metzer GV 1mg/500mg/0.3mg Tablet ER

Diabetic patients using the anti-diabetic medication, Glycema Trio 1mg/500mg/0.3mg Extended-Release tablets, should adhere to their physician's prescribed dosage. This combination therapy is indicated for managing type 2 diabetes in adults by regulating blood glucose levels. Always ingest the tablets with food, consistently at the same time daily for optimal effectiveness. Dosage adjustments may occur based on blood sugar monitoring. Continuous use is crucial; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Glycema Trio is one component of a comprehensive diabetes management plan, which includes a balanced diet, regular physical activity, and weight management as recommended by your healthcare provider. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain is another potential consequence. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. This medication should be used with caution during pregnancy and lactation; medical consultation is mandatory. Regular blood glucose monitoring is vital, along with potential blood tests to assess blood cell counts and liver function, as determined by your doctor.

Primary Ingredients of Metzer GV 1mg/500mg/0.3mg Tablet ER

No text provided to rephrase.

Uses of Metzer GV 1mg/500mg/0.3mg Tablet ER

Managing type 2 diabetes

Major Benefits of Metzer GV 1mg/500mg/0.3mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Metzer GV 1mg/500mg/0.3mg Extended-Release tablets should be administered on an empty stomach.

Common Side effects of Metzer GV 1mg/500mg/0.3mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Metzer GV 1mg/500mg/0.3mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Metzer GV 1mg/500mg/0.3mg Extended-Release tablets should be consumed on an empty stomach.

How Metzer GV 1mg/500mg/0.3mg Tablet ER works:

Extended-release Metzer GV tablets (1mg/500mg/0.3mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metzer GV 1mg/500mg/0.3mg Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Metzer GV 1mg/500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release formulation of Metzer GV (1mg/500mg/0.3mg) is likely unsuitable for breastfeeding mothers. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Metzer GV 1mg/500mg/0.3mg Extended-Release tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, Metzer GV 1mg/500mg/0.3mg Extended-Release tablets are unsuitable for those with severe kidney disease.

LiverLiverCAUTION

Patients with liver disease should use Metzer GV 1mg/500mg/0.3mg Extended-Release tablets cautiously. Dosage modification may be necessary for these patients. Consult a physician for guidance. A low starting dose is usually recommended for individuals with mild to moderate liver impairment; the medication is typically not prescribed for those with severe liver disease.

What if you forget to take Metzer GV 1mg/500mg/0.3mg Tablet ER :

Should you forget to take a Metzer GV 1mg/500mg/0.3mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metzer GV 1mg/500mg/0.3mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metzer GV 1mg/500mg/0.3mg Tablet ER

Metzer GV 1mg/500mg/0.3mg Extended-Release Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 diabetes.
Metzer GV 1mg/500mg/0.3mg ER Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infection.
Metzer GV 1mg/500mg/0.3mg Tablet ER is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Metzer GV 1mg/500mg/0.3mg ER tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metzer GV 1mg/500mg/0.3mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metzer GV 1mg/500mg/0.3mg...
104
MRP 120
13% off